Deflaza Tablet 30 mg contains Deflazacort 30 mg, a corticosteroid used to reduce inflammation and modulate the immune response in a variety of conditions. Deflazacort is a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is widely prescribed for conditions where controlling inflammation or overactive immune responses is critical.
Inflammation is a natural response of the body to injury or infection, but excessive or chronic inflammation can lead to tissue damage and complications. Deflazacort works by suppressing the production of inflammatory mediators and modulating immune system activity, helping manage symptoms such as swelling, pain, and redness.
Deflaza Tablet 30 mg is used in both acute and chronic inflammatory conditions, including autoimmune disorders, allergic reactions, and certain musculoskeletal and respiratory conditions. Its relatively favorable safety profile makes it a preferred corticosteroid in long-term management, with lower risk of weight gain and metabolic side effects compared to some other glucocorticoids.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Deflaza Tablet 30 mg is indicated for:
Inflammatory conditions such as arthritis, bursitis, and tendinitis
Autoimmune disorders including lupus, polymyositis, and dermatomyositis
Allergic reactions, severe asthma, and chronic obstructive pulmonary disease exacerbations
Duchenne muscular dystrophy to slow disease progression and improve muscle strength
Management of acute flare-ups in chronic inflammatory or autoimmune diseases
Potent anti-inflammatory and immunosuppressive effect
Reduces swelling, redness, and pain in affected areas
Helps control autoimmune reactions and flare-ups
Supports muscle function in conditions like Duchenne muscular dystrophy
Lower risk of certain corticosteroid-associated side effects compared to traditional glucocorticoids
Deflazacort exerts its effect by binding to glucocorticoid receptors, which regulate the expression of anti-inflammatory proteins and suppress the production of pro-inflammatory cytokines. This reduces the activity of immune cells and decreases the release of inflammatory mediators, controlling both acute and chronic inflammation.
The dosage of Deflaza Tablet 30 mg should be individualized according to the patient’s condition, disease severity, and response to therapy. Tablets are generally taken orally with water, with or without food.
For chronic conditions, the lowest effective dose should be used to minimize side effects.
In acute conditions, higher doses may be required for a short duration.
Gradual dose tapering is recommended when discontinuing therapy to prevent withdrawal symptoms and adrenal insufficiency.
Long-term use may lead to increased susceptibility to infections.
Use cautiously in patients with diabetes, hypertension, osteoporosis, or gastrointestinal disorders.
Regular monitoring of blood pressure, blood sugar, and bone health is advised during prolonged therapy.
Avoid abrupt discontinuation of therapy without medical supervision.
Inform the physician about all other medications being taken to avoid potential interactions.
Deflaza Tablet 30 mg is generally well tolerated. Potential side effects may include:
Weight gain and fluid retention
Increased blood sugar levels
Mood changes or sleep disturbances
Increased risk of infections
Long-term use may affect bone density
Most side effects are manageable with proper dosing and monitoring.
Store below 30°C in a dry, cool place, protected from light. Keep out of reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet